GlassScriptPhysician profile
Glenn J Kaufman
NPI 1518056373
$2,259.48
in general payments reported to CMS, 2019-2025
25 companies · $43.02 in 2025
The $43.02 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $637 · 2020: $106 · 2021: $592 · 2022: $608 · 2023: $242 · 2024: $30.90 · 2025: $43.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $623.00 | 2019-2021 | |
| Aspira Women'S Health INC | $397.34 | 2019-2022 | |
| Hologic Sales and Service, LLC | $222.40 | 2019-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
| Abbvie INC. | $216.43 | 2019-2023 | |
| Pfizer INC. | $117.04 | 2021-2022 | |
| Coopersurgical, INC. | $101.44 | 2019-2023 | Paragard T 380a, Endosee |
| Lupin INC. | $83.39 | 2019-2020 | |
| Allergan, INC. | $65.25 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $59.43 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.35 | 2022 | |
| Scynexis, INC. | $41.44 | 2022 | |
| Meditrina | $39.15 | 2022-2023 | |
| Roche Diagnostics Corporation | $37.76 | 2019-2021 | |
| Astellas Pharma US INC | $31.48 | 2023 | Myrbetriq, Veozah |
| Becton, Dickinson and Company | $25.46 | 2023 | Arista Ah Flexitip |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $17.51 | 2020 | |
| Agile Therapeutics, INC. | $17.01 | 2021 | |
| Duchesnay USA Incorporated | $17.00 | 2019 | |
| Organon LLC | $16.84 | 2022 | |
| Evofem Biosciences, INC. | $16.82 | 2022 | |
| Vertical Pharmaceuticals, LLC | $14.52 | 2019 | |
| Therapeuticsmd, INC. | $13.53 | 2019 | |
| Exeltis, USA INC. | $13.35 | 2021 | |
| Myovant Sciences INC. | $13.21 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.